![[logo] US EPA](https://webarchive.library.unt.edu/eot2008/20090507223643im_/http://www.epa.gov/epafiles/images/logo_epaseal.gif){kind=logo}
Nanotechnology: Scott E. McNeil
Highlights
February 12, 2008 - Read the Federal Register notice about EPA's Nanotechnology Research Strategy and meeting to review public comment:
- FR Notice Requesting Public comment on EPA's Nanotechnology Research Strategy and comment review meeting (PDF) (3 pp, 53 K)
- EPA's draft Nanotechnology Research Strategy (PDF) (76 pp, 1.10 MB)
 |
Nanotechnology Search
Dr. McNeil serves as Director, Nanotechnology Characterization Laboratory for the National Cancer Institute at Frederick where he conducts preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics. He has advised Industry and State and US Governments on the development of nanotechnology and is a member of several governmental and industrial working groups related to nanotechnology policy, standardization and commercialization. Prior to joining NCI-Frederick (i.e. SAIC-Frederick), he served for three years as Senior Scientist in the Nanotech Initiatives Division at SAIC where he transitioned basic nanotechnology research to government and commercial markets. Dr. McNeil's professional career includes tenure as an Army Officer, with tours as Chief of Biochemistry at Tripler Army Medical Center, and as a Combat Arms officer in the Gulf War. He is an invited speaker to numerous nanotechnology-related conferences and has six patents pending related to nanotechnology and biotechnology. He received his bachelor's degree in chemistry from Portland State University and his doctorate in cell biology from Oregon Health Sciences University.